Insurance Appeals Statistics and Outcomes: What the Data Shows

Insurance appeal outcomes are measurable, publicly tracked, and reveal systematic patterns in how insurers and review bodies resolve disputed claims. This page examines aggregated data on appeal filing rates, overturn frequencies, and outcome distributions across health, property, and employer-sponsored plan contexts. Understanding what the data shows matters because it shapes how policyholders, regulators, and plan administrators evaluate the practical utility of the appeals process.

Definition and scope

Insurance appeals statistics encompass quantitative records of how often policyholders challenge claim denials, how those challenges are resolved, and at what rates initial decisions are reversed. The data originates from federal agencies, state insurance departments, court filings, and independent review organization (IRO) reports compiled under state and federal mandates.

Scope boundaries matter here. Health insurance appeals data is the most systematically collected in the United States, largely because the Affordable Care Act (ACA) and the Employee Retirement Income Security Act (ERISA) impose disclosure and reporting obligations on insurers and plan administrators. Property and auto insurance outcome data is tracked less uniformly, with primary collection happening at the state level through insurance department complaint and appeal logs.

The National Association of Insurance Commissioners (NAIC) compiles aggregate complaint and appeal data across lines of insurance and publishes it through its Consumer Insurance Search database. The NAIC's Complaint Index benchmarks insurer performance against industry medians — a complaint ratio of 1.0 represents the median, with higher ratios indicating above-median complaint volumes relative to premium written. For a broader picture of how appeal rights are structured before examining outcomes, the insurance appeals process overview provides the procedural foundation.

How it works

Appeal outcome data flows through a layered reporting structure:

1. Internal appeal records — Insurers track and in many cases report internal appeal volumes and outcomes to state regulators under market conduct rules.
2. External review reports — IROs accredited under state law or federal standards submit outcome data to state insurance departments or the U.S. Department of Health and Human Services (HHS).
3. State department aggregation — State insurance commissioners publish annual market conduct reports and complaint databases.
4. Federal aggregation — HHS aggregates external review data for ACA-compliant plans under 45 CFR § 147.136, which governs internal claims and appeals procedures for non-grandfathered group and individual health plans.

The HHS external review data covers decisions made by certified IROs for marketplace and fully insured group plans. ERISA plans — which cover the majority of employer-sponsored workers — are subject to Department of Labor (DOL) oversight under 29 CFR § 2560.503-1, and their internal appeals data is disclosed through Form 5500 filings and DOL enforcement actions, though granular overturn rates are not centrally published in the same manner.

For the mechanics of external review specifically, external review process insurance and independent review organizations IROs address the procedural and institutional frameworks that generate this data.

Common scenarios

Health insurance external review data produced under the ACA offers the most granular publicly available appeal outcomes:

• According to HHS data reported through the CMS External Review Reports, overturn rates at the external review stage have ranged between 39% and 45% in published annual cycles for ACA-compliant plans — meaning nearly 4 in 10 external reviews result in the insurer's denial being overturned.
• Internal appeal overturn rates vary by plan and insurer, but market conduct examinations by state departments have documented internal reversal rates below 20% for many commercial carriers, underscoring the gap between internal and external outcomes.
• For Medicare Advantage plans, the Centers for Medicare & Medicaid Services (CMS) publishes annual data on Part C and Part D appeals. In the 2022 reporting cycle, Medicare Advantage enrollees who pursued reconsideration by a Qualified Independent Contractor (QIC) saw favorable outcomes (full or partial reversals) at rates exceeding 70% for certain service categories, per CMS published statistics.

Contrast this with property insurance appeals: because most property disputes are resolved through the appraisal clause, state department complaint proceedings, or litigation rather than a formalized internal-then-external review pipeline, aggregate overturn data is far less standardized. The appealing a property insurance denial page covers the structural differences.

Mental health parity appeals present a distinct data pattern. The insurance appeals for denied mental health claims context shows that denials citing "not medically necessary" for behavioral health services face heightened scrutiny under the Mental Health Parity and Addiction Equity Act (MHPAEA), with federal enforcement by DOL and HHS driving increased reversal rates in audited plans.

Decision boundaries

Interpreting appeal statistics requires understanding the conditions under which data is and is not comparable:

ACA external review vs. ERISA internal appeals — ACA external review produces IRO-level decisions with high reversal visibility. ERISA internal appeals produce plan-level decisions without equivalent mandatory public reporting, making direct comparison unreliable.

Fully insured vs. self-funded plans — State external review mandates apply to fully insured plans. Self-funded ERISA plans are exempt from state external review requirements (29 U.S.C. § 1144), meaning a large portion of privately insured workers' appeals fall outside the publicly tracked IRO dataset.

Claim type segmentation — Overturn rates differ substantially by denial type. Prior authorization denials, experimental treatment denials, and out-of-network claim disputes each carry different baseline reversal frequencies. The medical necessity appeals and experimental treatment appeals pages address the specific evidentiary thresholds that drive these divergences.

Temporal completeness — States publish market conduct data on varying schedules; some lag by 18 to 24 months, limiting real-time benchmarking.

The practical implication of these boundaries is that published overturn percentages describe a filtered population — those who filed, whose plans were subject to reporting requirements, and whose appeals reached the tracked stage. The consumer rights in insurance disputes framework details how policyholders can access insurer-specific performance records through state department public filings.

References

• National Association of Insurance Commissioners (NAIC) — Consumer Insurance Search
• U.S. Department of Health and Human Services — CMS External Review Data and Resources
• Centers for Medicare & Medicaid Services — Medicare Health Plan Appeals
• U.S. Department of Labor — ERISA Claims Procedure Regulation, 29 CFR § 2560.503-1
• Electronic Code of Federal Regulations — 45 CFR § 147.136 (ACA Internal Claims and Appeals)
• U.S. House Office of the Law Revision Counsel — 29 U.S.C. § 1144 (ERISA Preemption)
• HealthCare.gov — Health Care Law Protections (ACA)